Perfluorodecalin-enriched fibrin matrix for human islet culture

Biomaterials

Volumn 32, Issue 35, 2011, Pages 9282-9289

  Maillard, Elisa ^a,b   Juszczak, Maciej T ^a   Clark, Anne ^b   Hughes, Stephen J ^a,b   Gray, Derek R W ^a   Johnson, Paul R V ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Cell culture; Diabetes; Fibrin; Fluorocarbon; Islet; Scaffold; Transplantation

Indexed keywords

ACTIVE CASPASE-3; CASPASE-3 ACTIVATION; CELL DAMAGE; CHEMICAL ENVIRONMENT; FIBRIN; FIBRIN MATRIX; FOUR-GROUP; HUMAN ISLETS; HYPOXIA MARKER; IN-VITRO; ISLET; ISOLATION AND CULTURE; MATRIX; MICROENVIRONMENTS; OXYGEN DIFFUSION; PANCREATIC ISLET; PERFLUORODECALIN; PROINSULIN;

ANIMAL CELL CULTURE; CELL CULTURE; CELL DEATH; DAMAGE DETECTION; EMULSIFICATION; FLUOROCARBONS; INSULIN; MEDICAL PROBLEMS; SCAFFOLDS; TRANSPLANTATION (SURGICAL);

OXYGEN SUPPLY;

CASPASE 3; FIBRIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; PERFLUORODECALIN; PROINSULIN; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INSULIN RELEASE; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANOXIA; CELL NUCLEUS; EXTRACELLULAR MATRIX; FIBRIN; FLUOROCARBONS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INSULIN; ISLETS OF LANGERHANS; ORGAN CULTURE TECHNIQUES; PROTEIN TRANSPORT; TISSUE SURVIVAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053582346     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.044     Document Type: Article

References (39)

1. Chow L.W., Wang L.J., Kaufman D.B., Stupp S.I. Self-assembling nanostructures to deliver angiogenic factors to pancreatic islets. Biomaterials 2010, 31:6154-6161.
2. Shimizu H., Ohashi K., Utoh R., Ise K., Gotoh M., Yamato M., et al. Bioengineering of a functional sheet of islet cells for the treatment of diabetes mellitus. Biomaterials 2009, 30:5943-5949.
3. Hammar E., Parnaud G., Bosco D., Perriraz N., Maedler K., Donath M., et al. Extracellular matrix protects pancreatic beta-cells against apoptosis: role of short- and long-term signaling pathways. Diabetes 2004, 53:2034-2041.
4. Andrades P., Asiedu C., Rodriguez C., Goodwin K.J., McCarn J., Thomas J.M. Subcutaneous pancreatic islet transplantation using fibrin glue as a carrier. Transplant Proc 2007, 39:191-192.
5. Stendahl J.C., Kaufman D.B., Stupp S.I. Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell Transplant 2009, 18:1-12.
6. Daoud J.T., Petropavlovskaia M.S., Patapas J.M., Degrandpre C.E., Diraddo R.W., Rosenberg L., et al. Long-term in vitro human pancreatic islet culture using three-dimensional microfabricated scaffolds. Biomaterials 2011, 32:1536-1542.
7. Bachmann F. Fibrinolytic agents. Fibrinolysis 1995, 9:9-15.
8. Beattie G.M., Montgomery A.M., Lopez A.D., Hao E., Perez B., Just M.L., et al. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 2002, 51:3435-3439.
9. Johansson U., Rasmusson I., Niclou S.P., Forslund N., Gustavsson L., Nilsson B., et al. Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes 2008, 57:2393-2401.
10. Lim J.-Y., Min B.-H., Kim B.-G., Han H.-J., Kim S.-J., Kim C.-W., et al. A fibrin gel carrier system for islet transplantation into kidney subcapsule. Acta Diabetol 2009, 46:243-248.
11. Griffith C.K., Miller C., Sainson R.C., Calvert J.W., Jeon N.L., Hughes C.C., et al. Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng 2005, 11:257-266.
12. Buchwald P. FEM-based oxygen consumption and cell viability models for avascular pancreatic islets. Theor Biol Med Model 2009, 6:5.
13. Moritz W., Meier F., Stroka D.M., Giuliani M., Kugelmeier P., Nett P.C., et al. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J 2002, 16:745-747.
14. Lau J., Henriksnas J., Svensson J., Carlsson P.O. Oxygenation of islets and its role in transplantation. Curr Opin Organ Transplant 2009, 14:688-693.
15. Nadithe V., Bae Y.H. Hemoglobin conjugates with antioxidant enzymes (hemoglobin-superoxide dismutase-catalase) via poly(ethylene glycol) crosslinker for protection of pancreatic beta RINm5F cells in hypoxia. Tissue Eng Part A 2011, ahead of print. doi:10.1089/ten.tea.2010.0509.
16. 2 delivery by low-p50 hemoglobin: a new basis for hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 2005, 33:1-12.
17. Juszczak M.T., Elsadig A., Kumar A., Muzyamba M., Pawelec K., Powis S.H., et al. Use of perfluorodecalin for pancreatic islet culture prior to transplantation: a liquid-liquid interface culture system-preliminary report. Cell Transplant 2011, 20:323-332.
18. Riess J.G. Perfluorocarbon-based oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol 2006, 34:567-580.
19. Biro G.P., Blais P. Perfluorocarbon blood substitutes. Crit Rev Oncol Hematol 1987, 6:311-374.
20. Krafft M.P., Chittofrati A., Riess J.G. Emulsions and microemulsions with a fluorocarbon phase. Curr Opin Colloid Interface Sci 2003, 8:251-258.
21. Riess J.G. Injectable oxygen carriers (blood substitutes) - raison d'être, chemistry, and some physiology. Chem Rev 2001, 101:2797.
22. Maillard E., Sanchez-Dominguez M., Kleiss C., Langlois A., Sencier M.C., Vodouhe C., et al. Perfluorocarbons: new tool for islets preservation in vitro. Transplant Proc 2008, 40:372-374.
23. Nahmias Y., Kramvis Y., Barbe L., Casali M., Berthiaume F., Yarmush M.L. A novel formulation of oxygen-carrying matrix enhances liver-specific function of cultured hepatocytes. FASEB J 2006, 20:2531-2533.
24. Sanchez Dominguez M., Maillard E., Krafft M.P., Sigrist S., Belcourt A. Prevention of adhesion and promotion of pseudoislets formation from a beta-cell line by fluorocarbon emulsions. ChemBioChem 2006, 7:1160-1163.
25. Shapiro A.M., Ricordi C., Hering B.J., Auchincloss H., Lindblad R., Robertson R.P., et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006, 355:1318-1330.
26. Kin T., Senior P., O'Gorman D., Richer B., Salam A., Shapiro A.M. Risk factors for islet loss during culture prior to transplantation. Transpl Int 2008, 21:1029-1035.
27. Edamura K., Ohgawara H., Nasu K., Iwami Y., Sato A., Ishikawa S., et al. Effect of the extracellular matrix on pancreatic endocrine cell function and its biocompatibility in dogs. Cell Transplant 2001, 10:493-498.
28. Nagata N., Gu Y., Hori H., Balamurugan A.N., Touma M., Kawakami Y., et al. Evaluation of insulin secretion of isolated rat islets cultured in extracellular matrix. Cell Transplant 2001, 10:447-451.
29. Oberg-Welsh C. Long-term culture in matrigel enhances the insulin secretion of fetal porcine islet-like cell clusters in vitro. Pancreas 2001, 22:157-163.
30. Nagata N.A., Inoue K., Tabata Y. Co-culture of extracellular matrix suppresses the cell death of rat pancreatic islets. J Biomater Sci Polym Ed 2002, 13:579-590.
31. Thomas F.T., Contreras J.L., Bilbao G., Ricordi C., Curiel D., Thomas J.M. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery 1999, 126:299-304.
32. Weber L.M., Hayda K.N., Anseth K.S. Cell-matrix interactions improve β-cell survival and insulin secretion in three-dimensional culture. Tissue Eng Part A 2008, 14:1959-1968.
33. Kidszun A., Schneider D., Erb D., Hertl G., Schmidt V., Eckhard M., et al. Isolated pancreatic islets in three-dimensional matrices are responsive to stimulators and inhibitors of angiogenesis. Cell Transplant 2006, 15:489-497.
34. de Groot M., Schuurs T.A., van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 2004, 121:141-150.
35. Giuliani M., Moritz W., Bodmer E., Dindo D., Kugelmeier P., Lehmann R., et al. Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemia. Cell Transplant 2005, 14:67-76.
36. Carlsson P.O., Liss P., Andersson A., Jansson L. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 1998, 47:1027-1032.
37. Johnson A.S., Fisher R.J., Weir G.C., Colton C.K. Oxygen consumption and diffusion in assemblages of respiring spheres: Performance enhancement of a bioartificial pancreas. Chem Eng Sci 2009, 64:4470-4487.
38. Johnson A.S., O'Sullivan E., D'Aoust L.N., Omer A., Bonner-Weir S., Fisher R.J., et al. Quantitative assessment of islets of langerhans encapsulated in alginate. Tissue Eng Part C Methods 2011, 17:435-449.
39. Khattak S.F., Chin K.-s., Bhatia S.R., Roberts S.C. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol Bioeng 2007, 96:156-166.